Last reviewed · How we verify

NCT04399174

Placental Vasculature for Prediction of Recurrent Fetal Growth Restriction

Completed Last updated 22 May 2020
What this trial tests

trial testing US in Obstetric Complication in 200 participants. Completed in 15 January 2020.

Timeline
15 December 2016
Primary endpoint
20 May 2019
15 January 2020

Quick facts

Lead sponsorBenha University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date15 December 2016
Primary completion20 May 2019
Estimated completion15 January 2020

Drugs / interventions tested

Conditions studied

Sponsor

Benha University

Who can join

Eligibility, female only, with Obstetric Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

: In this Prospective longitudinal observational study, two hundred pregnant women with singleton pregnancy from 11 up to 13 weeks with history of intrauterine growth restriction in a previous pregnancy underwent ultrasound assessment of gestational age , ultrasound assessment of uterine artery pulsatility index, placental volume by 3D ultrasound and placental vascularization by 3D power Doppler (3DPD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of US

Trials testing the same drug.

Other recruiting trials for Obstetric Complication

Currently open trials in the same condition.

Other Benha University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04399174.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing